Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$21.25 Million ≈ $669.40K USD) by net assets (NT$1.71 Billion ≈ $53.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Johnson Chemical Pharmaceutical Works Co for the company's overall valuation and market capitalisation.

Johnson Chemical Pharmaceutical Works Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their cash flow conversion efficiency. Explore 4747 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Atara Biotherapeutics Inc NASDAQ:ATRA	0.267x
Advanced Braking Technology Ltd AU:ABV	0.134x
Ezwelfare Co Ltd KQ:090850	0.020x
Creative Realities Inc NASDAQ:CREX	-0.042x
Asphere Innovations Public Company Limited BK:AS	0.054x
Ihlas Gayrimenkul Proje Gelistirme ve Ticaret AS IS:IHLGM	0.012x
BluMetric Environmental Inc V:BLM	-0.001x
Kriti Industries (India) Limited NSE:KRITI	-0.022x

Annual Cash Flow Conversion Efficiency for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024. View current stock price of Johnson Chemical Pharmaceutical Works Co for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.70 Billion ≈ $53.68 Million	NT$62.88 Million ≈ $1.98 Million	0.037x	-54.95%
2023-12-31	NT$1.67 Billion ≈ $52.68 Million	NT$136.95 Million ≈ $4.31 Million	0.082x	-20.39%
2022-12-31	NT$871.66 Million ≈ $27.46 Million	NT$89.69 Million ≈ $2.83 Million	0.103x	+66.72%
2021-12-31	NT$848.24 Million ≈ $26.72 Million	NT$52.35 Million ≈ $1.65 Million	0.062x	-26.21%
2020-12-31	NT$858.20 Million ≈ $27.04 Million	NT$71.77 Million ≈ $2.26 Million	0.084x	-0.84%
2019-12-31	NT$847.97 Million ≈ $26.72 Million	NT$71.52 Million ≈ $2.25 Million	0.084x	+3.52%
2018-12-31	NT$836.53 Million ≈ $26.36 Million	NT$68.15 Million ≈ $2.15 Million	0.081x	+70.61%
2017-12-31	NT$835.43 Million ≈ $26.32 Million	NT$39.89 Million ≈ $1.26 Million	0.048x	-41.76%
2016-12-31	NT$832.41 Million ≈ $26.23 Million	NT$68.25 Million ≈ $2.15 Million	0.082x	+60.49%
2015-12-31	NT$821.60 Million ≈ $25.88 Million	NT$41.97 Million ≈ $1.32 Million	0.051x	-60.87%
2014-12-31	NT$635.01 Million ≈ $20.01 Million	NT$82.91 Million ≈ $2.61 Million	0.131x	-3.19%
2013-12-31	NT$583.53 Million ≈ $18.38 Million	NT$78.70 Million ≈ $2.48 Million	0.135x	+80.40%
2012-12-31	NT$386.30 Million ≈ $12.17 Million	NT$28.88 Million ≈ $909.94K	0.075x	-47.75%
2011-12-31	NT$353.39 Million ≈ $11.13 Million	NT$50.57 Million ≈ $1.59 Million	0.143x	+66.91%
2010-12-31	NT$324.45 Million ≈ $10.22 Million	NT$27.81 Million ≈ $876.26K	0.086x	-7.16%
2009-12-31	NT$311.47 Million ≈ $9.81 Million	NT$28.76 Million ≈ $906.10K	0.092x	--

About Johnson Chemical Pharmaceutical Works Co Ltd

TWO:4747 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$35.18 Million

NT$1.12 Billion TWD

Market Cap Rank

#23324 Global

#1443 in Taiwan

Share Price

NT$24.85

Change (1 day)

+0.00%

52-Week Range

NT$24.60 - NT$77.00

All Time High

NT$115.60